| Jonathan Andrew Mcfadyen, NP | |
|
1501 Ne Medical Center Dr, Bend, OR 97701-6051 | |
| (541) 382-2811 | |
| Not Available |
| Full Name | Jonathan Andrew Mcfadyen |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 14 Years |
| Location | 1501 Ne Medical Center Dr, Bend, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003136334 | NPI | - | NPPES |
| 500623623 | Medicaid | OR | |
| 00936658 | Other | OR | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 201050079NP (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bend Memorial Clinic Pc | 7214936533 | 201 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia, 41 percent of surveyed European hematologist-oncologists say that the favorable efficacy profile of Roche's MabThera (rituximab) is the most significant driver of their use of this brand, while 26 percent say MabThera's favorable risk-benefit profile is the most significant driver.
A common class of blood pressure drugs called angiotensin-receptor blockers may be linked with a slightly increased risk of developing cancer, US scientists have found.
According to trials, a new obesity drug, Tesofensine, which may be launched on the world market in a few years, can produce weight loss twice that of currently approved obesity drugs. The Danish company Neurosearch and a number of researchers at the Faculty of Life Sciences at University of Copenhagen are behind the promising findings.
The manufacturer of the experimental Ebola drug ZMapp says it has put other business on hold since August to boost production of the medication. Meanwhile, news outlets look at the government's authority to screen airline travelers, the House action to release additional funding for disease-fighting efforts and the Dallas hospital's defense of its treatment of the West African man who died of the disease this week.
Rice University biomedical engineers have developed a new technique for growing cartilage from human embryonic stem cells, a method that could be used to grow replacement cartilage for the surgical repair of knee, jaw, hip, and other joints.
› Verified 8 days ago
| Entity Name | Bend Memorial Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699827477 PECOS PAC ID: 7214936533 Enrollment ID: O20061215000022 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia, 41 percent of surveyed European hematologist-oncologists say that the favorable efficacy profile of Roche's MabThera (rituximab) is the most significant driver of their use of this brand, while 26 percent say MabThera's favorable risk-benefit profile is the most significant driver.
A common class of blood pressure drugs called angiotensin-receptor blockers may be linked with a slightly increased risk of developing cancer, US scientists have found.
According to trials, a new obesity drug, Tesofensine, which may be launched on the world market in a few years, can produce weight loss twice that of currently approved obesity drugs. The Danish company Neurosearch and a number of researchers at the Faculty of Life Sciences at University of Copenhagen are behind the promising findings.
The manufacturer of the experimental Ebola drug ZMapp says it has put other business on hold since August to boost production of the medication. Meanwhile, news outlets look at the government's authority to screen airline travelers, the House action to release additional funding for disease-fighting efforts and the Dallas hospital's defense of its treatment of the West African man who died of the disease this week.
Rice University biomedical engineers have developed a new technique for growing cartilage from human embryonic stem cells, a method that could be used to grow replacement cartilage for the surgical repair of knee, jaw, hip, and other joints.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Andrew Mcfadyen, NP 1501 Ne Medical Center Dr, Bend, OR 97701-6051 Ph: (541) 382-2811 | Jonathan Andrew Mcfadyen, NP 1501 Ne Medical Center Dr, Bend, OR 97701-6051 Ph: (541) 382-2811 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia, 41 percent of surveyed European hematologist-oncologists say that the favorable efficacy profile of Roche's MabThera (rituximab) is the most significant driver of their use of this brand, while 26 percent say MabThera's favorable risk-benefit profile is the most significant driver.
A common class of blood pressure drugs called angiotensin-receptor blockers may be linked with a slightly increased risk of developing cancer, US scientists have found.
According to trials, a new obesity drug, Tesofensine, which may be launched on the world market in a few years, can produce weight loss twice that of currently approved obesity drugs. The Danish company Neurosearch and a number of researchers at the Faculty of Life Sciences at University of Copenhagen are behind the promising findings.
The manufacturer of the experimental Ebola drug ZMapp says it has put other business on hold since August to boost production of the medication. Meanwhile, news outlets look at the government's authority to screen airline travelers, the House action to release additional funding for disease-fighting efforts and the Dallas hospital's defense of its treatment of the West African man who died of the disease this week.
Rice University biomedical engineers have developed a new technique for growing cartilage from human embryonic stem cells, a method that could be used to grow replacement cartilage for the surgical repair of knee, jaw, hip, and other joints.
› Verified 8 days ago
Mr. Nicholas J Campo Iii, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 233 Sw Wilson Ave Ste 201, Bend, OR 97702 Phone: 541-382-8862 Fax: 541-382-8928 | |
Elaine Michele Brown, RN ARNP PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2100 Ne Neff Rd Ste B, Bend, OR 97701 Phone: 541-647-2132 Fax: 541-728-0109 | |
Molly K Torvik, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2195 Ne Professional Ct Ste 1, Bend, OR 97701 Phone: 541-322-9396 | |
Jennifer Nicole Herr, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2255 Nw Shevlin Park Rd Ste 150, Bend, OR 97703 Phone: 541-706-5777 Fax: 541-429-6642 | |
Samantha Mullis, NNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-382-4321 Fax: 541-706-7068 | |
Thomas Eugene Coehlo, RN, MSN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 132 Sw Crowell Way Ste 100, Bend, OR 97702 Phone: 541-385-5515 Fax: 541-385-5578 |